Product image of Zolgensma (Onasemnogene Abeparvovec) supplied by GNH India

Zolgensma

Active Ingredient:
Onasemnogene Abeparvovec
Origin:
EU

Zolgensma (Onasemnogene Abeparvovec)

Zolgensma (onasemnogene abeparvovec) is a gene therapy for spinal muscular atrophy (SMA) in pediatric patients. Administered as a one-time intravenous infusion. Prescription required. Always consult a healthcare professional before use.

Manufacturer / TM Owner

Novartis Europharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zolgensma is used to treat spinal muscular atrophy (SMA), a genetic disorder affecting muscle control and movement. It replaces the missing or faulty SMN1 gene with a functional copy to improve motor function and survival. This therapy is typically administered to infants and young children diagnosed with SMA. It is not a cure but may significantly alter the disease’s progression.

Side Effects

  • After administration, Zolgensma works to produce the SMN protein, which supports motor neuron function and muscle control. Patients may experience gradual improvements in muscle strength, motor skills, and respiratory function over time. The effects vary by individual and depend on factors like age at treatment and baseline disease severity. Regular monitoring by a healthcare provider is recommended to assess progress.

Precautions & Warnings

  • Zolgensome should only be administered by a qualified healthcare professional in a clinical setting. Patients may require premedication to reduce the risk of infusion-related reactions. Close monitoring for signs of liver toxicity, low platelet counts, or elevated troponin levels is essential during and after treatment. Ensure the patient’s vaccination status is up to date before starting therapy.

Avoid Interactions

  • Live vaccines should not be administered within one month before or after Zolgensma treatment due to potential interference with the immune response. Avoid concurrent use of systemic corticosteroids unless medically necessary, as they may affect the therapy’s efficacy. Other medications, including over-the-counter drugs, should be reviewed with a healthcare provider to prevent potential interactions.

Frequently Asked Questions

Zolgensma is used to treat spinal muscular atrophy (SMA) in pediatric patients by replacing the missing SMN1 gene.

Zolgensma is given as a one-time intravenous infusion in a clinical setting by a healthcare professional.

Zolgensma is typically prescribed for infants and young children diagnosed with SMA, subject to medical evaluation.

Common side effects may include elevated liver enzymes, low platelet counts, and infusion-related reactions.

Zolgensma is not a cure but may significantly improve motor function and alter the disease’s progression.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Onasemnogene Abeparvovec

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT